Selection of thrombolytic therapy for individual patients: Development of a clinical model

American Heart Journal

Volumn 133, Issue 6, 1997, Pages 630-639

  Califf, R M ^a   Woodlief, L H ^a   Harrell F E , Jr ^a   Lee, K L ^a   White, H D ^a   Guerci, A ^a   Barbash, G I ^a   Simes, R J ^a   Weaver, W D D ^a   Simoons, M L ^a   Topol, E J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ARTICLE; CORONARY RISK; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NOMOGRAM; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030804064     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70164-9     Document Type: Article

References (24)

1. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
2. KL Lee RM Califf RJ Simes F Van de Werf EJ Topol for the GUSTO Investigators Holding GUSTO up to the light Ann Intern Med 120 1994 876 881
3. KL Lee LH Woodlief EJ Topol WD Weaver A Betriu J Col for the GUSTO-I Investigators Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients Circulation 91 1995 1659 1668
4. DR Cox The regression analysis of binary sequences (with discussion) J R Statist Soc B 20 1958 215 242
5. SH Walker DB Duncan Estimation of the probability of an event as a function of several independent variables Biometrika 54 1967 167 178
6. TF Devlin BJ Weeks Spline functions for logistic regression modeling Proceedings of the 11th Annual SAS Users Group International Conference 1986 646 651
7. FE Harrell KL Lee BG Pollock Regression models in clinical studies: determining relationships between predictors and response J Natl Cancer Inst 80 1988 1198 1202
8. PL Smith Splines as a useful and convenient statistical tool Am Statistician 33 1979 57 62
9. WS Cleveland Robust locally weighted regression and smoothing scatterplots J Amer Stat Assoc 74 1979 829 836
10. Harrell, FE. Design: S functions for biostatistical/epidemiological modeling, testing, estimation, validation, graphics, prediction, and typesetting. Programs available from statlib@lib.stat.cmu.edu.
11. ML Simoons AE Arnold Tailored thrombolytic therapy. A perspective Circulation 88 1993 2556 2564
12. E Boersma MJ van der Vlugt AE Arnold JW Deckers ML Simoons Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction Eur Heart J 17 1996 64 75
13. RM Califf EJ Topol F Van de Werf KL Lee L Woodlief for the GUSTO Investigators [abstract] One year followup from the GUSTO-I trial Circulation 90 Suppl I 1994 I325
14. MW Krucoff MA Croll JE Pope CB Granger KS Pieper KN Sigmon Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design J Electrocardiol 23 Suppl I 1990 6 10
15. S Yusuf R Peto J Lewis R Collins P Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Progr Cardiovasc Dis 27 1985 335 371
16. RM Califf FE Harrell Jr KL Lee JS Rankin MA Hlatky DB Mark The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective JAMA 261 1989 2077 2086
17. S Yusuf D Zucker P Peduzzi LD Fisher T Takaro JW Kennedy Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
18. WA Knaus FE Harrell CJ Fisher DP Wagner SM Opal JC Sadoff The clinical evaluation of new drugs for sepsis: a prospective study design based on survival analysis JAMA 270 1993 1233 1241
19. ME Farkouh JD Lang DL Sackett Thrombolytic agents: the science of the art of choosing the better treatment Ann Intern Med 120 1994 886 888
20. DB Mark CL Nelson RM Califf FE Harrell Jr KL Lee RH Jones The continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty Circulation 89 1994 2015 2025
21. WB Hillegass JG Jollis CB Granger EM Ohman RM Califf DB Mark Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction Am J Cardiol 73 1994 444 449
22. V Fuster Coronary thrombolysis a perspective for the practicing physician N Engl J Med 329 1993 723 725
23. EJ Topol RM Califf KL Lee More on the GUSTO trial N Engl J Med 331 1993 277 278
24. HM Krumholz RC Pasternak MC Weinstein GC Friesinger PM Ridker AN Tosteson Cost effectiveness of thrombolytic therapy in elderly patients with suspected acute myocardial infarction N Engl J Med 327 1992 7 13